Table 1.
Variable | N (%) | Variable | N (%) |
---|---|---|---|
Age, year | HER2 score | ||
Mean ± SD | 40.4 ± 22.35 | 0 | 6 (5.6) |
Range | 1–88 | 1 | 56 (52.3) |
2 | 36 (33.6) | ||
3 | 9 (8.4) | ||
Sex | HER2 status | ||
Male | 66 (61.7) | Negative | 62 (57.9) |
Female | 41 (38.3) | Positive | 45 (42.1) |
Tumor location | HER2, % | ||
Sellar | 2 (2.4) | Mean ± SD | 55.31 ± 28.15 |
Supratentorial | 63 (74.1) | Range | 0–100 |
Brain stem | 3 (3.5) | ||
Cerebellum | 17 (20) | ||
NA | 22 | ||
Complaints | HER2, % | ||
Lateralized | 18 (30) | ≤10 (−) | 6 (5.6) |
Generalized | 22 (36.7) | 11-50 (+) | 43 (40.2) |
Mixed | 20 (33.3) | ≥51 (++) | 58 (54.2) |
NA | 47 | ||
Tumor type | |||
LGA | 40 (37.4) | ||
HGA | 47 (43.9) | ||
Mixed oligoastrocytoma | 1 (0.9) | ||
PNET-SRCTLM | 17 (15.9) | ||
Hemangioblastoma | 1 (0.9) | ||
Choroid plexus papilloma | 1 (0.9) |
Abbreviations: PNET-SRCTLM, Primitive neuroectodermal tumor small round cell tumor lymphoma medulloblastoma; LGA, Low-grade astrocytoma; HGA, High-grade astrocytoma; SD, Standard deviation; NA, Not available.